You have decided that one of your patients, a 72-year-old, should add a basal insulin dose to her antihyperglycemic regimen. During your discussion with her, she voices concern that between her “arthritic hands and poor vision” she won’t be able to accomplish this. You make the recommendation that using an insulin pen will make injection easier for her. Which of the following statements regarding insulin pens is true? A. They all require loading with an insulin cartridge. B. They have more accurate dosing than syringes. C. They can now dose insulin in .10 units increments. D. They are now available for all types of insulin. Follow the link for the answer.

Are all your patients who use insulin pens trained and know how to use a vial and syringe? Follow the link to see how you and your colleagues compare.

Dr. Carla Greenbaum is the Director of the Diabetes Research Program at Benaroya Research Institute at Virginia Mason in Seattle, WA.

In this full interview transcript, Dr. Carla Greenbaum discusses her research into how to predict and prevent type 1 diabetes.

Dr. Carla Greenbaum discusses her role as Director of the Diabetes Research Program at Benaroya Research Institute, which focuses on the prediction and prevention of type 1 diabetes.

In part 1 of this Exclusive Interview, Dr. Carla Greenbaum explains the mission of her research in relation to efforts to cure type 1 diabetes in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 2 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about predicting diabetes, the ability to test for diabetes antibiodies in very young children, and steps to treat the disease early.

In part 3 of this Exclusive Interview, Dr. Carla Greenbaum explains the reason for disease modifying therapy in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 4 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the benefits of gene therapy and early detection even without a therapy yet in place.

In part 5 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of knowing the stages of diabetes.